Compare KMDA & OSPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KMDA | OSPN |
|---|---|---|
| Founded | 1990 | 1991 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 458.6M | 449.1M |
| IPO Year | 2013 | 2000 |
| Metric | KMDA | OSPN |
|---|---|---|
| Price | $8.70 | $10.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $14.00 | ★ $16.67 |
| AVG Volume (30 Days) | 74.8K | ★ 550.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 2.30% | ★ 4.86% |
| EPS Growth | N/A | ★ 28.77 |
| EPS | N/A | ★ 1.88 |
| Revenue | N/A | ★ $243,180,000.00 |
| Revenue This Year | $14.04 | $3.12 |
| Revenue Next Year | $7.99 | $3.42 |
| P/E Ratio | $24.59 | ★ $5.69 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.54 | $10.16 |
| 52 Week High | $9.35 | $18.13 |
| Indicator | KMDA | OSPN |
|---|---|---|
| Relative Strength Index (RSI) | 49.84 | 40.58 |
| Support Level | $6.69 | $10.26 |
| Resistance Level | $8.88 | $11.68 |
| Average True Range (ATR) | 0.28 | 0.41 |
| MACD | -0.08 | 0.02 |
| Stochastic Oscillator | 31.87 | 31.75 |
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.